Home|Journals|Articles by Year|Audio Abstracts

Review Article

J App Pharm Sci. 2017; 7(9): 243-251

Current and Emerging Therapies for the Management of Diabetic Retinopathy

Manodhini Elakkiya, Kousalya Selvaraj, Gowthamarajan Kuppuswamy.


Diabetes Mellitus (DM) has many complications, in which Diabetic Retinopathy (DR) is the major one. Blindness among working age people was due to DR. Retinal angiogenesis and retinal vascular permeability is the pathogenesis behind vision loss. Polyol pathway, protein kinase C (PKC) activation, renin angiotensin-aldosterone system (RAAS), oxidative stress etc are the pathophysiological pathways which are discussed in this review for better understanding. PKC inhibitors, anti-inflammatory agents, RAAS blockers, anti-vascular endothelial growth factor (VEGF) agents, antioxidants and fibrates which are the used for the better treatment for DR is also elaborated in this review.

Key words: Diabetic retinopathy, current therapies, emerging therapies,retinal neovascularisation, Anti-VEGF agents

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.